Prof O'Rahilly says that even if we solve the societal causes of obesity "there will be obese people and they will become ill", so he thinks the drugs will move us to a world of treating obesity "properly as a medical condition"
These findings which unlike many similar studies werent funded by the drugmaker itself add to the laundry list of health benefits associated with GLP-1s, which along with helping people lose weight have been linked to lowered alcohol and tobacco intake, better heart health, and other surprising positive side effects culminating in a conspicuously reduced overall chance of death
Most of the studies used once weekly subcutaneous injection of semaglutide starting at a dose of 0.25 mg and escalated every 4 weeks
Baseline testing was done one week prior to intraventricular infusion of MT-II or vehicle control, and repeat testing was performed on day nine of infusion
Whether youre looking to lighten your skin tone, detoxify your body, or boost your immune system, this treatment provides a versatile and effective solution